UY24130A1 - Peptido p277 analogos, y composiciones farmaceuticas que los comprenden para el tratamiento o diagnostico de diabetes. - Google Patents
Peptido p277 analogos, y composiciones farmaceuticas que los comprenden para el tratamiento o diagnostico de diabetes.Info
- Publication number
- UY24130A1 UY24130A1 UY24130A UY24130A UY24130A1 UY 24130 A1 UY24130 A1 UY 24130A1 UY 24130 A UY24130 A UY 24130A UY 24130 A UY24130 A UY 24130A UY 24130 A1 UY24130 A1 UY 24130A1
- Authority
- UY
- Uruguay
- Prior art keywords
- peptide
- sequence
- hsp60
- treatment
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Veterinary Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a nuevos peptidos que son variantes de un epitopo de la proteína de shock de calor humana de 60kDa (hsp60) y a las composiciones farmacéuticas que la comprenden y a los métodos para el diagnostico y el tratamiento de diabetes mellitus (IDM) dependiendo de insulina, mediante el uso de dichos péptidos. Un péptido que tiene la estructura de la secuencia p277 de hsp60 en la que uno o ambos residuos de cisteina son remplazados por residuos de valina y/o en la que el residuo thr19 es remplazado lys, que tiene sustancialmente la misma actividad biológica que p277 pero con estabilidad sustancialmente mejorada. Los nuevos análogos p277 pueden usarse para cualquier propósito en el que pueden usarse p277. Un equipo para diagnosticar la presencia de IDDM sometido a ensayo la presencia de anticuerpos anti hsp60 de acuerdo con el método que comprende: a- un antigeno que es un péptido de la secuencia (I); y b- un anticuerpo marcado que es capaz de reconocer la región no variable de dichos anticuerpos anti hsp60 que deben ser detectados. Una composición farmacéutica que comprende un péptido de secuencia, y un portador farmacéuticamente aceptable. Un método para la prevención o tratamiento de IDDM que comprende administrar a un sujeto humano una cantidad eficaz de un péptido de secuencia l, en un portador apropiado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11209494A IL112094A0 (en) | 1994-12-21 | 1994-12-21 | Novel peptides and pharmaceutical compositions comprising them |
IL11446095A IL114460A0 (en) | 1995-07-05 | 1995-07-05 | Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
UY24130A1 true UY24130A1 (es) | 1996-06-11 |
Family
ID=26322965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY24130A UY24130A1 (es) | 1994-12-21 | 1995-12-21 | Peptido p277 analogos, y composiciones farmaceuticas que los comprenden para el tratamiento o diagnostico de diabetes. |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0820303B1 (es) |
JP (2) | JP3420245B2 (es) |
KR (1) | KR100400480B1 (es) |
CN (1) | CN1233417C (es) |
AR (1) | AR002949A1 (es) |
AT (1) | ATE242005T1 (es) |
AU (1) | AU707835B2 (es) |
BR (1) | BR9510102A (es) |
CA (1) | CA2208274C (es) |
CZ (1) | CZ293784B6 (es) |
DE (2) | DE69531004T2 (es) |
DK (1) | DK0820303T3 (es) |
ES (1) | ES2201137T3 (es) |
FI (1) | FI118373B (es) |
HR (1) | HRP950612B1 (es) |
HU (1) | HU224160B1 (es) |
IL (1) | IL116499A0 (es) |
IS (1) | IS1966B (es) |
MX (1) | MX9704738A (es) |
NO (1) | NO317350B1 (es) |
NZ (1) | NZ301440A (es) |
PL (1) | PL184145B1 (es) |
PT (1) | PT820303E (es) |
RO (1) | RO116777B1 (es) |
RS (1) | RS49517B (es) |
SI (1) | SI0820303T1 (es) |
TR (1) | TR199501630A2 (es) |
TW (1) | TW496872B (es) |
UA (1) | UA42040C2 (es) |
UY (1) | UY24130A1 (es) |
WO (1) | WO1996019236A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6488933B2 (en) | 1995-07-05 | 2002-12-03 | Yeda Research And Development Co. Ltd. | Preparations for the treatment of T cell mediated diseases |
DE69724619T2 (de) * | 1996-05-14 | 2004-07-01 | Winnacker, Ernst-Ludwig, Prof. | Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können |
CA2420499A1 (en) * | 2000-08-25 | 2002-02-28 | Yeda Research And Development Co. Ltd. | Methods of treatment or prevention of autoimmune diseases with cpg-containing polynucleotide |
IL140233A0 (en) * | 2000-12-11 | 2002-02-10 | Peptor Ltd | Backbone cyclized analogs of heat shock proteins |
WO2003063759A2 (en) | 2002-01-31 | 2003-08-07 | Peptor Ltd. | Hsp peptides and analogs for modulation of immune responses via antigen presenting cells |
AU2005207891B2 (en) | 2004-01-28 | 2010-04-01 | Andromeda Biotech Ltd. | Hsp therapy in conjunction with a low antigenicity diet |
DE102004043750A1 (de) * | 2004-09-10 | 2006-03-30 | Sanofi-Aventis Deutschland Gmbh | Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität |
CN100352502C (zh) * | 2004-12-29 | 2007-12-05 | 中国药科大学 | 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因 |
WO2006072946A2 (en) | 2005-01-04 | 2006-07-13 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Hsp60, hsp60 peptides and t cell vaccines for immunomodulation |
US8211430B2 (en) | 2005-03-04 | 2012-07-03 | Curedm Group Holdings, Llc | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |
CA2609667C (en) | 2005-05-25 | 2011-02-22 | Curedm, Inc. | Human proislet peptide, derivatives and analogs thereof, and methods of using same |
JP4283812B2 (ja) * | 2006-01-06 | 2009-06-24 | 財団法人工業技術研究院 | 重症筋無力症の診断方法およびそのキット |
WO2008064306A2 (en) | 2006-11-22 | 2008-05-29 | Curedm, Inc. | Methods and compositions relating to islet cell neogenesis |
ES2534434T3 (es) | 2007-08-30 | 2015-04-22 | Curedm Group Holdings, Llc | Composiciones y métodos de uso de péptidos proislotes y análogos de los mismos |
CU23701A1 (es) * | 2008-12-29 | 2011-09-21 | Ct Ingenieria Genetica Biotech | Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i |
WO2013128453A1 (en) | 2012-03-01 | 2013-09-06 | Yeda Research And Development Co. Ltd. | Regeneration of islet beta cells by hsp60 derived peptides |
CN104244967A (zh) | 2012-03-01 | 2014-12-24 | 耶达研究与发展有限公司 | 用于抑制和治疗非自身免疫性糖尿病的Hsp60衍生肽和肽类似物 |
CN104418948B (zh) * | 2013-09-10 | 2019-08-16 | 深圳翰宇药业股份有限公司 | 一种制备多肽药物的方法 |
CN104650209B (zh) * | 2013-11-19 | 2018-04-06 | 深圳翰宇药业股份有限公司 | 多肽药物DiaPep277 的合成方法 |
CN104650244B (zh) * | 2015-01-21 | 2017-12-08 | 中国药科大学 | 一种具有降血糖兼调脂作用的表位组合肽及其用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5114844A (en) * | 1989-03-14 | 1992-05-19 | Yeda Research And Development Co., Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
-
1995
- 1995-12-20 MX MX9704738A patent/MX9704738A/es unknown
- 1995-12-20 NZ NZ301440A patent/NZ301440A/xx not_active IP Right Cessation
- 1995-12-20 DK DK95944502T patent/DK0820303T3/da active
- 1995-12-20 CZ CZ19971908A patent/CZ293784B6/cs not_active IP Right Cessation
- 1995-12-20 BR BR9510102A patent/BR9510102A/pt active IP Right Grant
- 1995-12-20 UA UA97063404A patent/UA42040C2/uk unknown
- 1995-12-20 WO PCT/US1995/016596 patent/WO1996019236A1/en active Search and Examination
- 1995-12-20 AU AU46866/96A patent/AU707835B2/en not_active Expired
- 1995-12-20 PT PT95944502T patent/PT820303E/pt unknown
- 1995-12-20 ES ES95944502T patent/ES2201137T3/es not_active Expired - Lifetime
- 1995-12-20 CA CA002208274A patent/CA2208274C/en not_active Expired - Lifetime
- 1995-12-20 CN CNB95197680XA patent/CN1233417C/zh not_active Expired - Lifetime
- 1995-12-20 SI SI9530664T patent/SI0820303T1/xx unknown
- 1995-12-20 DE DE69531004T patent/DE69531004T2/de not_active Expired - Lifetime
- 1995-12-20 RO RO97-01173A patent/RO116777B1/ro unknown
- 1995-12-20 DE DE0820303T patent/DE820303T1/de active Pending
- 1995-12-20 JP JP51996596A patent/JP3420245B2/ja not_active Expired - Fee Related
- 1995-12-20 HU HU9901771A patent/HU224160B1/hu active IP Right Grant
- 1995-12-20 EP EP95944502A patent/EP0820303B1/en not_active Expired - Lifetime
- 1995-12-20 PL PL95321091A patent/PL184145B1/pl unknown
- 1995-12-20 KR KR1019970704281A patent/KR100400480B1/ko not_active IP Right Cessation
- 1995-12-20 AT AT95944502T patent/ATE242005T1/de active
- 1995-12-21 UY UY24130A patent/UY24130A1/es unknown
- 1995-12-21 IL IL11649995A patent/IL116499A0/xx not_active IP Right Cessation
- 1995-12-21 TR TR95/01630A patent/TR199501630A2/xx unknown
- 1995-12-21 AR AR10071295A patent/AR002949A1/es unknown
- 1995-12-21 HR HR950612A patent/HRP950612B1/xx not_active IP Right Cessation
- 1995-12-21 RS YU78795A patent/RS49517B/sr unknown
-
1996
- 1996-01-05 TW TW085100088A patent/TW496872B/zh not_active IP Right Cessation
-
1997
- 1997-06-19 FI FI972669A patent/FI118373B/fi not_active IP Right Cessation
- 1997-06-19 NO NO19972849A patent/NO317350B1/no not_active IP Right Cessation
- 1997-06-19 IS IS4510A patent/IS1966B/is unknown
-
2003
- 2003-01-30 JP JP2003022033A patent/JP3554319B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY24130A1 (es) | Peptido p277 analogos, y composiciones farmaceuticas que los comprenden para el tratamiento o diagnostico de diabetes. | |
Lonberg-Holm et al. | Three high molecular weight protease inhibitors of rat plasma. Isolation, characterization, and acute phase changes. | |
RU98118184A (ru) | Пептидные иммуногены для вакцинации и лечения аллергии | |
ES2106721T3 (es) | Uso de amilina o cgrp para el tratamiento de la diabetes mellitus. | |
DE3855479D1 (de) | Hiv-peptide, künstliche hiv-antigene und immuntestsätze | |
BR9106303A (pt) | Imonogeno humano composicao,celula de mamifero,peptido,vacina contra sintomas de esclerose multipla,metodo para tratar ou prevenir doenca com sintomas de esclerose multipla e conjunto para diagnosticar esclerose multipla | |
AR033832A1 (es) | Un metodo ex vivo para diagnosticar una enfermedad autoinmune, anticuerpo, composicion de diagnostico que lo comprende, y usos del anticuerpo | |
DE69019190D1 (de) | Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung. | |
DE69638024D1 (de) | Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren | |
UY24270A1 (es) | Nuevos peptidos derivados de la proteína 60 humana por choque térmico para el tratamiento de diabetes, las composiciones, los métodos y equipos. | |
ES2118939T3 (es) | Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi. | |
ATE364701T1 (de) | Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren | |
Graindorge et al. | Radioimmunologic method for detection of antitubular basement membrane antibodies | |
Franklin et al. | The partial amino acid sequence of the major low molecular weight component of two human amyloid fibrils | |
DE3884316D1 (de) | Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung. | |
SE9001105D0 (sv) | New methods foer diagnosis of tuberculosis | |
Lee et al. | Scientific considerations for generic synthetic salmon calcitonin nasal spray products | |
ES2113356T3 (es) | Peptidos con un determinante antigenico caracteristico para alfa-1-micro-globulina. | |
Pootrakul et al. | Hemoglobin Siam α215argβ2: A new α-chain variant | |
KR930703444A (ko) | 어류 황체화 호르몬-방출 호르몬 동족체 | |
Huang et al. | Synthesis and bioactivities of two multiple antigen peptides as potential vaccine against schistosoma | |
KR970705578A (ko) | 신규의 면역피임 펩티드류(new immunocontraceptive peptides) | |
Blackwell et al. | Fast hemoglobin variant in Minahassan people of Sulawesi, Chinese and Thais: α2β256 Gly→ Asp | |
Kamada et al. | Preparation of a uveitogenic peptide by chymotryptic digestion of bovine S-antigen. | |
KR890009972A (ko) | 펩티드, 이의 제조방법, 항체를 수득하기 위한 이의 용도, 및 인간 혈액중의 pai 1 활성을 억제하기 위한 항체의 용도 |